Orphan designation: Ibrexafungerp Treatment of invasive candidiasis, 12/11/2021 Positive
Orphan designation: Epetraborole Treatment of nontuberculous mycobacterial lung disease, 10/08/2022 Positive
Orphan designation: Fosmanogepix Treatment of invasive aspergillosis, 18/07/2022 Positive
Orphan designation: Fosmanogepix Treatment of invasive candidiasis, 18/07/2022 Positive
Orphan designation: erlotinib Treatment of pachyonychia congenita, 18/07/2022 Positive
Orphan designation: Fosmanogepix Treatment of scedosporiosis, 20/03/2023 Positive
Orphan designation: Fosmanogepix Treatment of lomentosporiosis, 15/02/2023 Positive
Orphan designation: Fosmanogepix Treatment of mucormycosis, 15/02/2023 Positive
EMEA-003220-PIP01-22
CHMP PROM minutes for the meeting on 15 July 2024